Compare stocks

2invest AG is a Germany-based investment company that acquires, holds, manages, and sells investments in corporations and partnerships, primarily within the biotechnology, life sciences, and information technology sectors, both domestically and internationally. The company was formerly known as 4basebio AG and rebranded to 2invest AG in January 2021. Headquartered in Heidelberg, Germany, 2invest AG focuses on identifying and supporting emerging companies with strong management teams and innovative technologies, aiming to enable these companies to reach significant value inflection points.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.